Englebert Financial Advisers, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 2097035 Allentown, PA

Position in VKTX

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$456,377

+$73,284 QoQ

Shares Held

11,699

-0.6% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

1.98%

of 13F equity value

Holder Rank

#227

of 432 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Englebert Financial Advisers, LLC holds $1,106,212 across 3 Biotechnology names. VKTX ranks #1 (41.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc. This page	11,699	$456,377
2	PRAX	Praxis Precision Medicines, Inc.	1,306	$437,235
3	VRTX	Vertex Pharmaceuticals Inc / Ma	428	$212,600

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$456,377	11,699	-0.6%	Shares	Sole	2026-07-22
2026-03-31	$383,093	11,773	+0.1%	Shares	Sole	2026-04-22
2025-12-31	$413,751	11,761	—	Shares	Sole	2026-02-04
No filing history on record for this holder in this stock.